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The interstitial space of the dermis maintains an 
open one-way communication with the lym-
phatic system. A constant interstitial flux drags 
serum components filtrated from the capillary 
bed toward the initial lymphatic vessels that are 
equipped with flap valves to allow entry but 
prevent  exit  of  solutes  and  small  particles 
(Swartz, 2001; Trzewik et al., 2001). Patrolling 
immune cells like lymphocytes (Debes et al., 
2005) and DCs (Alvarez et al., 2008), but also 
hematopoietic  stem  cells  (Massberg  et  al., 
2007), follow the same principal route. Whereas 
fluid flux is driven by the periodic contractions 
of the lymphatic suction pump (Swartz, 2001), 
cells  rely  on  autonomous  action  and  crawl 
through the interstitium toward and into the 
initial  lymphatic  vessel.  The  major  guidance 
cues for this migration are chemokines that are 
expressed by the lymphatic endothelium and 
sensed by hematopoietic cells (Alvarez et al., 
2008).  We  recently  showed  that  leukocytes 
crawl through the interstitium without specific 
integrin-mediated contacts with their environ-
ment. This mode of locomotion is driven by 
the  protrusive  forward  flow  of  polymerizing 
actin and occasionally supported by actomyosin 
contractions of the rear end to squeeze the rigid 
nucleus through narrow spaces (Lämmermann 
et al., 2008). Such movement is facilitated   
by extreme plasticity of the cell body, which 
led to the morphological description “amoe-
boid” migration (Friedl et al., 2001). Integrin-
independent  movement  is  mainly  limited   
to three-dimensional environments (Hawkins 
et al., 2009) with large pore size, but fails when 
the cells have to move along two-dimensional 
surfaces or penetrate dense or stiff barriers like 
basement membranes (BMs) or endothelial lin-
ings (Lämmermann et al., 2008). The crossing 
of the blood endothelium is a well-investigated 
example where leukocytes require a cascade of 
tightly controlled molecular interactions to dis-
solve and penetrate the junctional sealing of the 
cell layer (Butcher and Picker, 1996; Ley et al., 
2007). Hence, we were surprised to find that 
DCs do not require integrin-mediated cell–
cell  and  cell–matrix  interactions  to  enter 
lymphatics of mouse dermis and wondered 
how  the  vessel  architecture  might  support 
cellular entry.
Here, we demonstrate that lymphatics are 
covered by a BM, but that this BM is discon-
tinuous especially in the initial lymphatics that 
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Although both processes occur at similar rates, leukocyte extravasation from the blood 
circulation is well investigated, whereas intravasation into lymphatic vessels has hardly 
been studied. In contrast to a common assumption—that intra- and extravasation follow 
similar molecular principles—we previously showed that lymphatic entry of dendritic cells 
(DCs) does not require integrin-mediated adhesive interactions. In this study, we demon-
strate that DC-entry is also independent of pericellular proteolysis, raising the question of 
whether lymphatic vessels offer preexisting entry routes. We find that the perilymphatic 
basement membrane of initial lymphatic vessels is discontinuous and therefore leaves gaps 
for entering cells. Using a newly developed in situ live cell imaging approach that allows us 
to dynamically visualize the cells and their extracellular environment, we demonstrate that 
DCs enter through these discontinuities, which are transiently mechanically dilated by the 
passaging cells. We further show that penetration of the underlying lymphatic endothelial 
layer occurs through flap valves lacking continuous intercellular junctions. Together, we 
demonstrate free cellular communication between interstitium and lymphatic lumen.
© 2009 Pflicke and Sixt  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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et al., 2008) that restrict proteolytic activity to the site of po-
tential invasion (Gimona et al., 2008). Intravasation was entirely 
dependent on directional sensing via CCR7, as CCR7-
deficient DCs neither approached nor entered lymphatic ves-
sels (Fig. S3 A), supporting previous findings that CCR7 is 
the key factor mediating intravasation (Förster et al., 1999; 
Ohl et al., 2004).
The perilymphatic BM is discontinuous
As the data strongly argued against active path generation 
by DCs, we investigated preformed anatomical entry routes 
as a second possible explanation for our initial observations. 
Hence, we investigated the structural features of the lymphatic 
BM of ear skin in more detail.
In thin-section histology, the lymphatic BM is not easily 
detectable (Petrova et al., 2004; Vainionpää et al., 2007). 
When we performed whole-mount immunohistology of ear 
skin, we obtained a clear signal around LYVE-1–positive lym-
phatic vessels for all essential BM components (Fig. 2); colla-
gen IV, laminins, perlecan, and nidogen formed a sheet around 
the blind-ending initial lymphatic vessels. Co-localization of 
all components was perfect in this area, although nidogen was 
also detectable in patches within the dermis (Fig. 2 B), which 
is in line with its expression by dermal fibroblasts (Breitkreutz 
et al., 2004). Together with immunoelectronmicroscopy 
studies that showed an electron-dense structure associated 
with type IV collagens and laminin at the outline of lymphatics 
(Sauter et al., 1998), this argues for a regularly assembled BM 
at the abluminal lymphatic surface.
In comparison to the continuous appearance of blood 
capillary and fat cell BMs, the lymphatic BM showed a lower 
fluorescence  signal  and  discontinuities  (Fig.  2  A).  Higher 
magnification views and three-dimensional reconstructions 
revealed that the discontinuities were not sites of low expres-
sion of single BM components as shown for the perivenular 
BM (Wang et al., 2006), but rather areas completely devoid 
of any of the analyzed BM components (Fig. 2 B).
Lymphatic vessels can be subdivided in the blind ending 
initial lymphatic capillaries and the draining collector vessels. 
Collectors are characterized by no LYVE-1, but maintained 
gp38 expression (Mäkinen et al., 2005). Co-staining of gp38, 
LYVE-1, and collagen IV revealed that in contrast to lymphatic 
capillaries the BM of collectors is not perforated (Fig. 3, A and 
B).  We  morphometrically  quantified  the  perforated  surface 
area in relation to the total lymph vessel surface and found that 
the perforated area was <5% in collectors, whereas in lym-
phatic capillaries it accounted for up to 30% of the total vessel 
area (Fig. 3 C). Using the identical morphometric intensity 
thresholding for blood vessels, we could not detect any per-
forated areas in the same tissue samples. The “low expression 
sites” that serve as exit sites for granulocytes extravasating via 
postcapillary venule BMs (Wang et al., 2006) could only be 
detected when intensity thresholds were reduced, confirming 
that these areas are indeed regions of low BM molecule deposi-
tion rather than true perforations as they are found in the lym-
phatics (unpublished data).
serve as entry sites for blood cells. We show that DCs enter 
the lymphatics by squeezing through these preformed pores 
and subsequent passage through the flap valves of the lym-
phatic endothelium that lack continuous junctions. Such 
entry via preformed routes is in line with our findings that 
proteases and integrins are dispensable for intravasation.
RESULTS AND DISCUSSION
Two modes of DC migration into lymphatic vessels
We used a novel in situ live cell imaging approach to follow 
DC  migration  in  explanted  ear  sheets  of  mice.  In  these 
“crawl-in” assays, split ear sheets were fluorescently stained 
with antibodies against either laminin or collagen IV to visu-
alize BMs in the dermis. The ear sheets were mounted onto 
the  bottom  of  climatized  migration  chambers  and  subse-
quently fluorescently labeled mature bone marrow–derived 
DCs (bmDCs) or endogenous DCs were added. After a 
short incubation that allowed the DCs to infiltrate the der-
mis, the preparation was imaged with spinning disc confo-
cal microscopy.
The BM staining allowed morphological identification of 
arteries, veins, associated nerves, fat cells, and lymphatic ves-
sels. Initial lymphatic vessels were characterized by their blind 
endings and their large and irregular diameter (Baluk et al., 
2007). DCs selectively and directionally approached and en-
tered the lymphatic vessels and after 90–120 min, almost all 
DCs had entered the lumen (Fig. 1 A and Video 1). Quanti-
fication of crawl-in videos revealed two types of behavior 
once the cells reached the BM of the lymphatic vessel: some 
cells slowed close to the BM before they again accelerated in 
the lumen of the vessel, whereas others migrated straight into 
the lumen (Fig. 1 B and Video 1).
We reasoned that this pattern emerged because initially 
entering DCs might create a path that is then used by the 
DCs that follow. Path generation through BMs was mainly 
attributed to the MMP family of proteases (Rowe and Weiss, 
2008).  However,  to  additionally  exclude  effects  by  other 
proteases, we applied a previously described protease inhibi-
tor cocktail that was shown to block any pericellular proteo-
lytic activity in vitro and in vivo (Wolf et al., 2003). We 
tracked  single-cell  velocities  of  intravasating  bmDCs  and 
could neither detect reduced interstitial migration speeds nor 
hampered intravasation (Fig. 1, C and E). To control this ap-
proach, we quantified migration of bmDCs across an in vitro 
assembled BM: to this end, long-term cultured immortalized 
epithelial cells were lysed off of filters, revealing a tightly 
assembled  BM  (Furuyama  and  Mochitate,  2000  and  not 
depicted). bmDCs were layered onto these BMs and transmi-
gration was quantified after overnight exposure. In this setup, 
applying  the  protease  inhibitor  cocktail  entirely  inhibited 
transmigration (Fig. 1 D), which is in line with a study show-
ing that epidermal DCs require MMPs to cross the epidermal 
BM (Ratzinger et al., 2002).
The finding that pericellular proteolysis was dispensable 
for lymphatic entry was consistent with our previous data that 
intravasation was also independent of integrins (Lämmermann JEM VOL. 206, December 21, 2009  2927
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Figure 1.  DCs display two types of migration modes into lymphatic vessels. (A) Spinning disc confocal images (maximum projection of z-stack,  
22 planes, 0.5 µm distance) of labeled DCs (red) migrating into lymphatic vessels (BM stained for laminin, green) over time. See also Video 1. Bar, 50 µm.  
(B) Enlargement of inset in (A) representatively showing tracks of four different DCs. Bar, 20 µm. On the right of the panel instantaneous velocities of the 
DCs (tracks 1–4) are plotted over time. Arrival at the lymphatic vessel BM is marked by a red and appearance in the vessel lumen by a green arrow.  
(C) Average migration velocities in the presence of DMSO (control) or protease inhibitor cocktail (PIC). Control: 5 independent preparations, 56 cells 
tracked. PIC: 7 independent preparations, 61 cells tracked. Error bars show the mean ± SE of mean (SEM). ns, not significant. (D) DC migration across plain 
transwell (PET) vs. transwell carrying an in vitro assembled BM (BM) in the presence of DMSO (control) or PIC. One representative of two independent 
experiments. Each dot represents a single transwell used in the experiment. Error bars show mean ± SEM. ns, not significant. ***, P < 0.0001 (E) Confocal 
images of whole-mount ear skin 2 h after addition of exogenously labeled bmDCs. DCs were incubated before crawl-in assay with either DMSO (1) or 
protease inhibitor (2). Bar, 20 µm. Images are representatives of one of at least five independently performed crawl-in assays.2928 Dendritic cell entry into lymphatic vessels | Pflicke and Sixt
model for the human disease lymphedema distichiasis, ini-
tial lymphatics are aberrantly invested by pericytes (Petrova 
et al., 2004) and that this leads to the enhanced deposition 
of BM components in lymphatic capillaries. This suggests 
that either pericytes contribute directly to the BM or indi-
rectly influence the matrix production or deposition of the 
lymphatic endothelium.
Reasons for the fragility of this BM might be twofold: 
first, lymphatic endothelial cells express low levels of RNA 
coding for BM molecules (Podgrabinska et al., 2002; Hirakawa 
et al., 2003). Second, the initial lymphatics lack pericytes, 
which are an abundant source of BM constituents (Petrova 
et al., 2004; Hallmann et al., 2005). Interestingly, it was 
shown that in foxc2 knockout mice, which is the mouse 
Figure 2.  Discontinuous expression of BM components on initial lymphatic vessels. (A) Confocal images of whole-mount ear skin preparations. 
BMs were identified by staining for laminin (green) and lymphatic vessels were identified by staining for LYVE-1 (red), respectively. The following tissue 
structures can be distinguished: a, arteriole; b, vein; c, capillary; d, fat cell; e, lymphatic vessel. Bar, 100 µm. Insets 1 and 2 show higher magnification 
pictures of respective areas on initial lymphatics. Bar, 20 µm. (B) Co-localization of major BM components on initial lymphatics. Lymphatic vessel edges 
are outlined red. Note the clear contours of BM perforations (arrows). Asterisks show areas on a lymphatic vessel (top row) and blood vessel (middle row), 
which do not represent perforations but rather tangential sections of the vessels caused by the limited z volume. Bar, 20 µm. Images are representatives 
of one of at least 11 different tissues investigated.JEM VOL. 206, December 21, 2009  2929
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localization of collectors in our preparations, which is caused 
by the fact that collectors are buried deeper in the ear dermis 
than initial lymphatic vessels.
BM discontinuities are extended during cellular passage
The finding that BM penetration apparently requires neither 
biochemical remodelling nor specific adhesion prompted us 
to investigate possible extension forces imposed by the DCs 
squeezing through BM perforations. We therefore analyzed 
the distribution of BM immunostainings during cellular pas-
sage.  We  focused  on  intravasation  events  that  involved 
significant extension of BM perforations and found that fluo-
rescence intensity at the lateral margins of the entry hole in-
creased upon passage (Fig. 4 C). This indicates that the BM is 
not degraded, but rather pushed aside by hydrostatic forces 
DCs traverse the lymphatic BM via discontinuities
The discovery of BM discontinuities in lymphatic capillaries 
raised the possibility that these sites may be used as entry 
portals by approaching DCs. To address this possibility, we 
recorded high-magnification time-lapse z-series of bmDCs 
and lymph vessel BM.
Strikingly, in all cases where we could observe DCs en-
tering the lymphatic lumen, the cells used preexisting discon-
tinuities as entry sites. Approaching DCs inserted a protrusion 
into the BM perforation, and subsequently the cell body was 
propelled across the BM (Fig. 4, A and B, Fig. S1, and Videos 
S2–S6). Although it would be interesting to know if DCs are 
able to penetrate the unperforated BMs of collector vessels, 
we could never observe bmDCs approaching or entering at 
these sites (Fig. S4). This was despite the more superficial 
Figure 3.  Collecting lymphatic vessels show continuous BM. (A) Confocal images of whole-mount ear skin preparations. BMs were identified by 
staining for collagen IV (green) and initial lymphatic vessels were identified by staining for LYVE-1 (red) and gp38 (blue). Collectors were identified by the 
lack of a LYVE-1 staining, but preserved gp38 staining. Bar, 100 µm. Insets 1 and 2 show higher magnification images of respective areas on collecting 
lymphatics. Bar, 50 µm. (B) Enlargements of insets in A demonstrating the discontinuous BM assembly on initial lymphatics in a and c in stark contrast to 
BM assembly on collector lymphatic vessels (b and d). Note the even distribution of collagen IV in b and d orthogonal plane views compared with a and c. 
Bar, 20 µm. (C) Quantification of perforation area in relation to total lymphatic vessel area for initial and collector lymphatics. Every single vessel area 
analyzed was grouped according to the fraction of the BM perforation area of the whole vessel area analyzed. Images are representatives of one of at 
least nine different tissues investigated. For the quantification in C, 24 areas in 11 different tissues were analyzed for initial lymphatic vessels and 17 
areas in 9 different tissues were analyzed for collector lymphatic vessels.2930 Dendritic cell entry into lymphatic vessels | Pflicke and Sixt
after passage of large quantities of bmDCs. Using identical 
thresholding parameters, the number of perforations per area 
was not altered 90 min after addition of the cells, excluding 
de novo generation of perforations by migrating bmDCs 
(Fig. 5 A). To ensure that the migration pattern of bmDCs 
exerted by the DC (Fig. S2 and Videos S4–S6). Such defor-
mation is reminiscent of findings with amoeboid tumor cells 
migrating through collagen scaffolds (Wyckoff et al., 2006). 
To consolidate the aforementioned observation, we morpho-
metrically quantified the number of perforations before and 
Figure 4.  DCs dilate BM perforations. (A) Spinning disk confocal images (maximum projection of z-stack, 10 planes, 0.5 µm distance) of DCs (red) in 
close vicinity of an initial lymphatic vessel (BM staining: collagen IV, green; blood capillary also visible). Bar, 20 µm. (B) Inset of A showing the initial 
events of a single DC (red) entering the vessel lumen via a preexisting perforation (arrow; maximum projection of z-stack, 5 planes, 0.5 µm distance). Top 
row shows the top view onto vessel BM (collagen IV), the bottom row the corresponding sectional XZ-view (BM green; DC red). Bar, 5 µm. (C) Representa-
tive spinning disk confocal images of an initial lymphatic vessel showing the enlargement of perforations (BM staining: collagen IV) over a period of 1.5 h. 
Bar, 10 µm. Enlargements of insets 1–3 are shown on the right. Overlay images show perforation size at t = 0 h (green) and t = 1.5 h (red). Bar, 2 µm.  
A histogram plot of the line section across the perforation shows fluorescence intensity of collagen IV at t = 0 h in green and at t = 1.5 h in red. Images 
are representatives of one of at least nine independently performed crawl-in assays.JEM VOL. 206, December 21, 2009  2931
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Figure 5.  BM perforation dilation is a transient event. (A) Quantification of perforation number on initial lymphatic vessels in crawl-in assays at 
time points t = 1.5 h and t = 24 h. Six different tissues (up to two areas per tissue) were imaged at the indicated time points and analyzed morphometri-
cally. Perforation number and area at t = 0 h was set to 100%. Each dot represents one analyzed area. Error bars show mean ± SEM (B) Quantification of 
perforation area on initial lymphatic vessels in crawl-in assays at time points t = 0 h, t = 1.5 h, and t = 24 h. Six different tissues (up to two areas per 
tissue) were imaged at the indicated time points and analyzed morphometrically. (C) Initial lymphatic vessel (BM staining for collagen IV; blood capillary 
also visible in bottom right corner) visualized using a spinning disk confocal microscope (maximum projection of z-stack, 4 planes, 0.5 µm distance). Bar, 
20 µm. (D) Enlargement of inset in C showing perforation size at t = 0 h, t = 1.5 h, and after 24 h of addition of DCs to ear explant. Bar, 10 µm. (E) Repre-
sentative analysis of the perforation area after migration of DCs into the lumen of an initial lymphatic vessel. During the course of 24 h, BM perforations 
get dilated (1.5 h) and relax again (24 h). Enlargement of inset 1–3 in D showing perforation size at t = 0 h, t = 1.5 h, and after 24 h. Numbers below each 
image denote perforation area (red line) in square micrometers. Bars, 2 µm. Images are representatives of one of at least three independently performed 
crawl-in assays.2932 Dendritic cell entry into lymphatic vessels | Pflicke and Sixt
revealing their oak leaf structure with the peripheral lobes 
representing the flexible areas that are interconnected by but-
tons at their base. When the LYVE-1 pattern was imaged in 
ears without exogenously added DCs, the endothelial out-
lines  remained  static  (unpublished  data).  During  bmDC 
intravasation, the peripheral lobes of endothelial cells were 
locally deformed (Fig. 6, A and B; Videos S7 and S8) and 
analysis of z-time series supported a model where flaps bend 
into the lymphatic lumen during DC passage (Fig. 6, C and D) 
while  the  button-junctions  at  the  flap-base  remain  in 
position.  The  entry  via  gaps  between  button  junctions   
also resembles ultrastructural findings where metastasizing   
tumor cells were demonstrated to passage through “inter-
cellular channels” between the lymphatic endothelial cells 
(Azzali, 2007).
Our  finding  that  DCs  can  cross  the  lymphatic  vessel 
within a few minutes is in contrast to in vitro studies where 
DCs took 3–6 h to cross a monolayer of a lymphatic endo-
thelial cell line (Johnson et al., 2006). We explain these dif-
ferences  by  the  fact  that  lymphatic  monolayers  do  not 
assemble button junctions, but rather the zipperlike junctions 
of blood endothelium or lymphatic collector vessels (Kriehuber 
et al., 2001). Rapid intravasation via preformed portals is 
reminiscent of lymphocytes passaging through portals within 
the medullary sinus of the lymph node (Wei et al., 2005), 
with the exception that we never observed DCs reexiting 
from the lymph vessel. Preformed portals further explain our 
findings that integrin-deficient cells intravasate normally, 
which again corresponds well with the fact that homeostatic 
lymphatics do not express the cellular integrin ligands ICAM-1 
and VCAM-1 (Johnson et al., 2006; Teoh et al., 2009). 
This situation might change in the inflammatory state, where 
ICAM-1 and VCAM-1 are strongly induced on the lym-
phatics and adhesion gains functional importance (Johnson 
et al., 2006; Ledgerwood et al., 2008).
In conclusion, we find that a physical barrier is largely 
lacking at the level of the homeostatic lymphatic endothe-
lium, and therefore informational cues like chemokines are 
the  decisive  factors  guiding  the  cells  into  the  lymphatics. 
These findings support the concept of an open cellular com-
munication between interstitium and draining lymph node, 
and suggest that only the lymph node serves as the physiolog-
ical filtration station (Lämmermann and Sixt, 2008).
MATERIALS AND METHODS
Animals. C57BL/6 mice were kept in a conventional animal facility at the 
Max Planck Institute of Biochemistry. Mouse breeding and experimental 
procedures were approved by the Regierung von Oberbayern.
Generation of DCs. DCs were generated from flushed bone marrow sus-
pension as described previously (Lutz et al., 1999). At day 9–12 of culture, 
200 ng/ml LPS (Sigma-Aldrich; E. coli 0127:B8) was added overnight. En-
dogenous DCs were isolated by floating ventral sheets on culture medium 
(RPMI 1640 supplemented with 10% fetal calf serum, 1% glutamine, and 1% 
penicillin/streptomycin) for 72 h and pooling emigrated DCs. For imaging, 
cells were fluorescently labeled with Tetra-Methylrhodamine (Invitrogen).
does not differ from that of endogenous DCs we used DCs 
that previously emigrated from ear tissue. In crawl-in assays 
these cells also entered via preexisting perforations (Fig. S1), 
demonstrating that this mode of intravasation is universal 
for DCs.
The homeostatic dermis experiences a constant steady-
state flux of DCs and other hematopoietic cells, raising the 
possibility that these cells create the perforations. However, 
when we examined dermis of CCR7/ mice, where steady-
state migration of most hematopoietic cells, including DCs, is 
abolished (Ohl et al., 2004), we found the same surface area 
perforated (Fig. S3 B). This suggests that perforations are an 
intrinsic property of lymphatic capillaries rather than the re-
sult of continuously passaging cells.
Assuming a certain elasticity of the BM, deformations 
could be transient, as the locally compressed BM might relax 
and reextend after the cell has left the gap. To address if the 
BM reverts to its original state after DCs entered the vessel 
lumen, samples were left under assay conditions for 24 h and 
BM discontinuities were measured. Quantification showed 
that BMs partially relax after intravasation (Fig. 5, B–E), add-
ing to our previous evidence that proteolytic modification of 
the BM is not decisive for intravasation.
The finding that even small preexisting openings can be 
invaded by a cellular protrusion means that the lymphatic 
BM biophysically rather resembles a 3D scaffold than a sheet-
like barrier. Once the cell’s leading edge is inserted into a 
perforation, it can swell through actin polymerization and 
form an initial mechanical anchor. Subsequent trailing edge 
contraction  can  squeeze  cytoplasm  and  the  rigid  nucleus 
through the gap, as we have shown for DCs migrating in 
three-dimensional collagen gels (Lämmermann et al., 2008). 
Such behavior does not rely on transmembrane force cou-
pling  via  integrins  and  can  generate  sufficient  hydrostatic 
pressure to extend the pore to a diameter sufficient to propel 
the nucleus (Wolf et al., 2007; Lämmermann et al., 2008). 
Our observation that the BM becomes compressed at the 
pore margins and relaxes after passage clearly argues for such 
a biophysical rather than a proteolytic scenario.
DCs pass through endothelial flap valves
The lymphatic BM is the initial barrier for intravasating DCs, 
and directly after their passage DCs face the lymphatic endo-
thelium. Endothelial cells of the initial lymphatics are inter-
connected by specialized junctional complexes that contain 
components similar to blood vessel endothelium but are 
assembled in entirely different structures. Instead of the con-
tinuous zipperlike distribution found in blood endothelium, 
lymphatics show a buttonlike distribution of junctional com-
ponents. These buttons likely form the “hinges” of the flap 
valves. The spacing between the buttons was shown to be   
2–3 µm (Baluk et al., 2007), which might allow cellular pas-
sage without dissolution of junctions.
To test this assumption, we stained ear sheets with LYVE-1 
antibody and performed crawl-in assays. As described by 
Baluk et al. (2007), LYVE-1 outlined single endothelial cells JEM VOL. 206, December 21, 2009  2933
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Figure 6.  DCs enter vessel lumen via endothelial flap valves. (A, top) DCs (red) entering an initial lymphatic vessel stained with LYVE-1 (green), 
which highlights the outline of lymphatic endothelial cells. (bottom) LYVE-1 staining only; boxes highlight the areas displayed in B. Bars, 20 µm. (B) Time 
series of highlighted areas showing movement of endothelial cell edges upon entry of DCs. Bar, 2 µm. (C) LYVE-1 staining of an initial lymphatic vessel. 
Bar, 20 µm. (middle) Highlighted area where a DC enters. (right) The z-projected time series of the dotted line shown in the middle panel. Note the DC 
protrusion (red, asterisk) adjacent to the LYVE-1–positive structure that bends downward (into the vessel lumen). Bars, 2 µm. Images are representatives 
of one of eight independent experiments. (D) Schematic summarizing the findings. DCs (green) arrive via the interstitial matrix (IM) and encounter the 
porous BM of the initial lymphatic vessel. They enter by squeezing through the pores and subsequently encounter the lymphatic endothelial layer (LE). The 
oak leaf–shaped lymphatic endothelial cells are interconnected by junctional complexes organized as buttons (red) at the base of flexible lobes. DCs enter 
the endothelial layer without opening the junctions by pushing the flap valves into the vessel lumen (inset).2934 Dendritic cell entry into lymphatic vessels | Pflicke and Sixt
tion into lymphatic collectors. Video S1 shows a low-magnification view of 
lymphatic intravasation. Videos S2–S6 show DCs invading the lymphatic 
BM and Videos S7 and S8 show DCs interacting with the lymphatic en-
dothelium. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091739/DC1.
We thank Sylvia Cremer and all members of the Sixt laboratory for discussions and 
critical reading of the manuscript and Reinhard Fässler for continuous support.
This work was funded by the Peter Hans Hofschneider Foundation for 
Experimental Biomedicine, the German Research Foundation, and the Max Planck 
Society.
The authors declare that they have no conflicting financial interests.
Submitted: 10 August 2009
Accepted: 4 November 2009
REFERENCES
Alvarez, D., E.H. Vollmann, and U.H. von Andrian. 2008. Mechanisms 
and consequences of dendritic cell migration. Immunity. 29:325–342. 
doi:10.1016/j.immuni.2008.08.006
Azzali, G. 2007. Tumor cell transendothelial passage in the absorbing lym-
phatic  vessel  of  transgenic  adenocarcinoma  mouse  prostate.  Am.  J. 
Pathol. 170:334–346. doi:10.2353/ajpath.2007.060447
Baluk,  P.,  J.  Fuxe,  H.  Hashizume,  T.  Romano,  E.  Lashnits,  S.  Butz, 
D.  Vestweber,  M.  Corada,  C.  Molendini,  E.  Dejana,  and  D.M. 
McDonald.  2007.  Functionally  specialized  junctions  between  en-
dothelial  cells  of  lymphatic  vessels.  J.  Exp.  Med.  204:2349–2362. 
doi:10.1084/jem.20062596
Breitkreutz, D., N. Mirancea, C. Schmidt, R. Beck, U. Werner, H.J. Stark, 
M. Gerl, and N.E. Fusenig. 2004. Inhibition of basement membrane 
formation  by  a  nidogen-binding  laminin  gamma1-chain  fragment 
in  human  skin-organotypic  cocultures.  J.  Cell  Sci.  117:2611–2622. 
doi:10.1242/jcs.01127
Brown, J.C., T. Sasaki, W. Göhring, Y. Yamada, and R. Timpl. 1997. The 
C-terminal domain V of perlecan promotes beta1 integrin-mediated cell 
adhesion, binds heparin, nidogen and fibulin-2 and can be modified by 
glycosaminoglycans. Eur. J. Biochem. 250:39–46. doi:10.1111/j.1432-
1033.1997.t01-1-00039.x
Butcher, E.C., and L.J. Picker. 1996. Lymphocyte homing and homeostasis. 
Science. 272:60–66. doi:10.1126/science.272.5258.60
Clement, A., M.P. Steele, J.S. Brody, and N. Riedel. 1991. SV40T-
immortalized lung alveolar epithelial cells display post-transcriptional 
regulation of proliferation-related genes. Exp. Cell Res. 196:198–205. 
doi:10.1016/0014-4827(91)90251-O
Debes, G.F., C.N. Arnold, A.J. Young, S. Krautwald, M. Lipp, J.B. Hay, 
and E.C. Butcher. 2005. Chemokine receptor CCR7 required for T 
lymphocyte  exit  from  peripheral  tissues.  Nat.  Immunol.  6:889–894. 
doi:10.1038/ni1238
Farr, A., A. Nelson, and S. Hosier. 1992. Characterization of an antigenic 
determinant preferentially expressed by type I epithelial cells in the 
murine thymus. J. Histochem. Cytochem. 40:651–664.
Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. 
Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune re-
sponse by establishing functional microenvironments in secondary lym-
phoid organs. Cell. 99:23–33. doi:10.1016/S0092-8674(00)80059-8
Friedl, P., S. Borgmann, and E.B. Bröcker. 2001. Amoeboid leukocyte 
crawling through extracellular matrix: lessons from the Dictyostelium 
paradigm of cell movement. J. Leukoc. Biol. 70:491–509.
Furuyama, A., and K. Mochitate. 2000. Assembly of the exogenous extracel-
lular matrix during basement membrane formation by alveolar epithelial 
cells in vitro. J. Cell Sci. 113:859–868.
Gimona, M., R. Buccione, S.A. Courtneidge, and S. Linder. 2008. Assembly 
and biological role of podosomes and invadopodia. Curr. Opin. Cell 
Biol. 20:235–241. doi:10.1016/j.ceb.2008.01.005
Hallmann,  R.,  N.  Horn,  M.  Selg,  O.  Wendler,  F.  Pausch,  and  L.M. 
Sorokin.  2005.  Expression  and  function  of  laminins  in  the  embry-
onic and mature vasculature. Physiol. Rev. 85:979–1000. doi:10.1152/ 
physrev.00014.2004
Whole-mount ear skin immunohistology. Mice were sacrificed, and 
their ears were removed and separated into dorsal and ventral sheets. Cartilage-
free ventral ear sheets were fixed with 1% paraformaldehyde, immersed in 
0.2% Triton X-100, washed with PBS, blocked with 1% BSA (PAA Labora-
tories), and incubated with primary antibodies diluted in PBS 1% BSA over 
night at 4°C. The antibodies used were as follows: rabbit anti-collagen IV 
(1119+; T. Sasaki, Max Planck Institute of Biochemistry, Martinsried, 
Germany); rabbit anti-laminin (L9393; Sigma-Aldrich), rabbit anti-perlecan 
domain V (1056+; R. Timpl, Max Planck Institute of Biochemistry; Brown 
et al., 1997); rat anti-nidogen (ELM1; Millipore); rat polyclonal anti-LYVE-1 
antibody (clone 223322; R&D Systems); and hamster anti-gp38 (clone 8.1.1; Farr 
et al., 1992). Secondary antibodies were conjugated with cy3, cy5 (Jackson 
Immunoresearch Laboratories), Alexa Fluor 488, and Alexa Fluor 647 (Invi-
trogen). Images were acquired with a confocal laser-scanning microscope 
(Leica  DMIRE2;  objectives  HC  PL  APO  20×/0.70,  HCX  PL  APO 
63×/1.4-0.60, and HCX PL APO 100×/1.4-0.70), and image analysis was 
performed using Metamorph software (Molecular Devices).
Image analysis. Confocal z-stacks of lymph vessel walls were projected using 
the Metamorph maximum projection tool. Videos were processed using back-
ground subtraction and low-pass filter. To enhance Tetra-Methylrhodamine, 
staining of DCs  value was set to two in some cases. Perforation areas were 
quantified using manual thresholding, and subsequent measurement with the 
morphometric analysis tool of Metamorph.
In vitro transmigration assay. BMs were assembled in vitro using a mod-
ified protocol of Furuyama and Mochitate (Furuyama and Mochitate, 2000). 
In brief, SV40T2 immortalized alveolar type II epithelial cells (gift from A. 
Clement, Hopital Trousseau, Paris; Clement et al., 1991) were cultured in 
Transwell dishes (BD) supplemented with Matrigel (BD) for 2–3 wk and 
BMs were denuded using 0.25 M ammonium hydroxide and repeated wash-
ing with PBS.
Mature DCs were preincubated for 1 h at 37°C with protease inhibitor 
cocktail (Wolf et al., 2003) consisting of 50 µM GM6001 (Merck Chemi-
cals); 20 µM E-64 (Sigma-Aldrich); 20 µM pepstatin A (Sigma-Aldrich); 
2 µM leupeptin (Sigma-Aldrich); aprotinin (Chemicon); or carrier control. 
105 cells in 200 µl were added to the upper compartment of 8 µm pore size 
Transwells. 1 µg/ml CCL21 (R&D Systems) was added to the lower com-
partments, and after overnight incubation transmigrated DCs were counted 
with a hemocytometer.
Ex vivo crawl-in assay and time-lapse video microscopy. Unfixed 
ventral ear sheets were immunostained and mounted on custom-built migra-
tion chambers with the dermal surface exposed. TAMRA-labeled DCs in 
culture medium were added onto the dermis and incubated for 5–15 min at 
37°C, 5% CO2. After removing noninfiltrated DCs, ear sheets were imaged 
in a climatized (37°C, 5% CO2) chamber with a spinning-disk confocal mi-
croscope (Axio Observer Z1; Carl Zeiss, Inc.) equipped with EC Plan-
Neofluar  10×/0.30,  EC  Plan-Neofluar  20×/0.5,  and  Plan-Apochromat 
40×/0.95 objectives, an Optovar (1.6×), and a CoolSNAP HQ2 CCD camera 
(Visitron Systems).
Cell tracking. Cells were tracked using the “Manual Tracking Plug-in” 
of ImageJ (http://rsbweb.nih.gov/ij/) and analyzed with the “Chemo-
taxis and Migration Tool Plug-in” (http://www.ibidi.de/applications/ 
ap_chemo.html).
Statistical analysis. Student’s t tests were performed after data were con-
firmed to fulfill the criteria of normal distribution, and P values were calcu-
lated using the GraphPadPlus software.
Online supplemental material. Fig. S1 shows intravasation of endog-
enous DCs. Fig. S2 provides overview images of the Videos S4–S6. Fig. S3 
shows BMs in CCR7-deficient tissue, as well as migration of CCR7-
deficient DCs in crawl-in assays. Fig. S4 documents the lack of intravasa-JEM VOL. 206, December 21, 2009  2935
Brief Definitive Report
Hawkins,  R.J.,  M.  Piel,  G.  Faure-Andre,  A.M.  Lennon-Dumenil,  J.F. 
Joanny, J. Prost, and R. Voituriez. 2009. Pushing off the walls: a mech-
anism of cell motility in confinement. Phys. Rev. Lett. 102:058103. 
doi:10.1103/PhysRevLett.102.058103
Hirakawa,  S.,  Y.K.  Hong,  N.  Harvey,  V.  Schacht,  K.  Matsuda,  T. 
Libermann, and M. Detmar. 2003. Identification of vascular lineage-
specific genes by transcriptional profiling of isolated blood vascular and 
lymphatic endothelial cells. Am. J. Pathol. 162:575–586.
Johnson, L.A., S. Clasper, A.P. Holt, P.F. Lalor, D. Baban, and D.G. Jackson. 
2006. An inflammation-induced mechanism for leukocyte transmigra-
tion across lymphatic vessel endothelium. J. Exp. Med. 203:2763–2777. 
doi:10.1084/jem.20051759
Kriehuber,  E.,  S.  Breiteneder-Geleff,  M.  Groeger,  A.  Soleiman,  S.F. 
Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer. 2001. Isolation 
and characterization of dermal lymphatic and blood endothelial cells 
reveal  stable  and  functionally  specialized  cell  lineages.  J.  Exp.  Med. 
194:797–808. doi:10.1084/jem.194.6.797
Lämmermann, T., and M. Sixt. 2008. The microanatomy of T-cell responses. 
Immunol. Rev. 221:26–43. doi:10.1111/j.1600-065X.2008.00592.x
Lämmermann,  T.,  B.L.  Bader,  S.J.  Monkley,  T.  Worbs,  R.  Wedlich-
Söldner, K. Hirsch, M. Keller, R. Förster, D.R. Critchley, R. Fässler, 
and M. Sixt. 2008. Rapid leukocyte migration by integrin-independent 
flowing and squeezing. Nature. 453:51–55. doi:10.1038/nature06887
Ledgerwood, L.G., G. Lal, N. Zhang, A. Garin, S.J. Esses, F. Ginhoux, M. 
Merad, H. Peche, S.A. Lira, Y. Ding, et al. 2008. The sphingosine 
1-phosphate receptor 1 causes tissue retention by inhibiting the entry of 
peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 
9:42–53. doi:10.1038/ni1534
Ley, K., C. Laudanna, M.I. Cybulsky, and S. Nourshargh. 2007. Getting to 
the site of inflammation: the leukocyte adhesion cascade updated. Nat. 
Rev. Immunol. 7:678–689. doi:10.1038/nri2156
Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rössner, F. Koch, N. Romani, 
and G. Schuler. 1999. An advanced culture method for generating large 
quantities of highly pure dendritic cells from mouse bone marrow.  
J. Immunol. Methods. 223:77–92. doi:10.1016/S0022-1759(98)00204-X
Mäkinen, T., R.H. Adams, J. Bailey, Q. Lu, A. Ziemiecki, K. Alitalo, R. 
Klein, and G.A. Wilkinson. 2005. PDZ interaction site in ephrinB2 
is required for the remodeling of lymphatic vasculature. Genes Dev. 
19:397–410. doi:10.1101/gad.330105
Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo, 
E.A. Moseman, I.V. Huff, T. Junt, A.J. Wagers, I.B. Mazo, and U.H. 
von  Andrian.  2007.  Immunosurveillance  by  hematopoietic  progeni-
tor cells trafficking through blood, lymph, and peripheral tissues. Cell. 
131:994–1008. doi:10.1016/j.cell.2007.09.047
Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T. 
Blankenstein, G. Henning, and R. Förster. 2004. CCR7 governs skin 
dendritic cell migration under inflammatory and steady-state conditions. 
Immunity. 21:279–288. doi:10.1016/j.immuni.2004.06.014
Petrova, T.V., T. Karpanen, C. Norrmén, R. Mellor, T. Tamakoshi, D. 
Finegold, R.  Ferrell,  D. Kerjaschki,  P. Mortimer,  S.  Ylä-Herttuala, 
et al. 2004. Defective valves and abnormal mural cell recruitment un-
derlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 
10:974–981. doi:10.1038/nm1094
Podgrabinska, S., P. Braun, P. Velasco, B. Kloos, M.S. Pepper, and M. Skobe. 
2002. Molecular characterization of lymphatic endothelial cells. Proc. 
Natl. Acad. Sci. USA. 99:16069–16074. doi:10.1073/pnas.242401399
Ratzinger, G., P. Stoitzner, S. Ebner, M.B. Lutz, G.T. Layton, C. Rainer, 
R.M. Senior, J.M. Shipley, P. Fritsch, G. Schuler, and N. Romani. 
2002. Matrix metalloproteinases 9 and 2 are necessary for the migration 
of Langerhans cells and dermal dendritic cells from human and murine 
skin. J. Immunol. 168:4361–4371.
Rowe, R.G., and S.J. Weiss. 2008. Breaching the basement membrane: 
who, when and how? Trends Cell Biol. 18:560–574. doi:10.1016/ 
j.tcb.2008.08.007
Sauter, B., D. Foedinger, B. Sterniczky, K. Wolff, and K. Rappersberger. 
1998. Immunoelectron microscopic characterization of human dermal 
lymphatic  microvascular  endothelial  cells.  Differential  expression  of 
CD31, CD34, and type IV collagen with lymphatic endothelial cells vs 
blood capillary endothelial cells in normal human skin, lymphangioma, 
and hemangioma in situ. J. Histochem. Cytochem. 46:165–176.
Swartz, M.A. 2001. The physiology of the lymphatic system. Adv. Drug 
Deliv. Rev. 50:3–20. doi:10.1016/S0169-409X(01)00150-8
Teoh, D., L.A. Johnson, T. Hanke, A.J. McMichael, and D.G. Jackson. 2009. 
Blocking development of a CD8+ T cell response by targeting lym-
phatic recruitment of APC. J. Immunol. 182:2425–2431. doi:10.4049/ 
jimmunol.0803661
Trzewik,  J.,  S.K.  Mallipattu,  G.M.  Artmann,  F.A.  Delano,  and  G.W. 
Schmid-Schönbein. 2001. Evidence for a second valve system in lym-
phatics: endothelial microvalves. FASEB J. 15:1711–1717. doi:10.1096/ 
fj.01-0067com
Vainionpää, N., R. Bützow, M. Hukkanen, D.G. Jackson, T. Pihlajaniemi, 
L.Y. Sakai, and I. Virtanen. 2007. Basement membrane protein distri-
bution in LYVE-1-immunoreactive lymphatic vessels of normal tissues 
and ovarian carcinomas. Cell Tissue Res. 328:317–328. doi:10.1007/ 
s00441-006-0366-2
Wang, S., M.B. Voisin, K.Y. Larbi, J. Dangerfield, C. Scheiermann, M. 
Tran, P.H. Maxwell, L. Sorokin, and S. Nourshargh. 2006. Venular 
basement membranes contain specific matrix protein low expression 
regions that act as exit points for emigrating neutrophils. J. Exp. Med. 
203:1519–1532. doi:10.1084/jem.20051210
Wei, S.H., H. Rosen, M.P. Matheu, M.G. Sanna, S.K. Wang, E. Jo, C.H. 
Wong, I. Parker, and M.D. Cahalan. 2005. Sphingosine 1-phosphate type 1 
receptor agonism inhibits transendothelial migration of medullary T cells 
to lymphatic sinuses. Nat. Immunol. 6:1228–1235. doi:10.1038/ni1269
Wolf, K., R. Müller, S. Borgmann, E.B. Bröcker, and P. Friedl. 2003. Amoeboid 
shape  change  and  contact  guidance:  T-lymphocyte  crawling  through   
fibrillar collagen is independent of matrix remodeling by MMPs and other 
proteases. Blood. 102:3262–3269. doi:10.1182/blood-2002-12-3791
Wolf, K., Y.I. Wu, Y. Liu, J. Geiger, E. Tam, C. Overall, M.S. Stack, and 
P. Friedl. 2007. Multi-step pericellular proteolysis controls the transi-
tion from individual to collective cancer cell invasion. Nat. Cell Biol. 
9:893–904. doi:10.1038/ncb1616
Wyckoff, J.B., S.E. Pinner, S. Gschmeissner, J.S. Condeelis, and E. Sahai. 
2006.  ROCK-  and  myosin-dependent  matrix  deformation  enables 
protease-independent tumor-cell invasion in vivo. Curr. Biol. 16:1515–
1523. doi:10.1016/j.cub.2006.05.065